Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy

Withdrawn before enrolling · Not applicable

Conditions studied: brca1 Mutation Carrier, brca2 Mutation Carrier, Ovarian Cancer

In brief

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of celecoxib before prophylactic oophorectomy may be an effective way to prevent the development of ovarian epithelial cancer. PURPOSE: A controlled pilot trial to study the effectiveness of celecoxib in preventing cancer in patients at high-risk for ovarian epithelial cancer who are undergoing prophylactic oophorectomy.

Key facts

Study ID
NCT00084370
Run by
University of Alabama at Birmingham
People needed
0
Starts
2002-06-01
Expected to finish
2005-03-01
Last updated by the study team
2013-08-22

Who can join

Age: 19 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.